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The global epidemic of hepatitis C virus (HCV) is 
among the leading causes of preventable death 
worldwide. In the United States, an estimated 2.7 
to 2.9 million people have chronic HCV infection 
[1]. 
 
As a positive stranded RNA virus, HCV has high 
mutation rates and can be classified into six 
major genotypes and approximately 80 subtypes.  
HCV shows a genetic diversity even in one 
individual. 
 
Circulating Hepatitis C virus (HCV) genotypes in 
Alaska have not been characterized. Genotyping 
HCV isolates is of specific clinical interest 
because genotyping is a significant predictor of 
the response to antiviral therapy and serves as a 
guideline for therapy duration. 
Introduction 
To examine hepatitis C virus (HCV) genome 
variation within a single patient by targeting two 
conserved regions for genotypic sequencing and 
phylogenetic analysis. 
Objective 
Methods 
Figure 3 Quantitative real time PCR amplification plot comparing 
three cDNA libraries. With respect to threshold cycle (CT=26.59), we 
evaluated efficiency of our cDNA library (3rd Library), which was 39x 
more effective than the reference library. 
Preliminary Results 
We have begun aligning individual sequence data 
obtained from a fragment covering the 5’UTR 
region.  
 
Results currently indicate  that there are two 
primary sequence variations with about 50% 
conservation. This suggests high levels of HCV 
genetic diversity within this patient sample.   
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Total RNA extraction 
Model 
Figure 2 Schematic of methodology: (i) RNA extraction, (ii) cDNA 
synthesis, (iii) cloning, and (iv) plasmid DNA preparation for sequencing 
[4,5]. 
Figure 1 Genotyping region of HCV: the most suitable region 
for genotyping are the 5’UTR, Core (C), E1 and NS5B [3].  In this 
study, target regions are the 5’UTR and NS5B region.   
Figure 3 Alignment of partial HCV 5’UTR sequences.  Four 
amplicons in the 5’UTR (216 bp) region were subject to Sanger 
Sequencing. Sequence data were aligned using CLC workbench 
software. Consensus between sequences 1 and 6 are nearly 100%. A 
similar relationship is observed between sequences 3 and 5.  However, 
overall consensus is approximately 50%. Identity sequences were 
compared using the basic local alignment search tool (BLAST) 
database, which provided 98-100% shared identity to subtype 1a. 
Serum from a chronically infected HCV-naïve patient 
was collected from the Alaska State Virology 
laboratory, from which multiple hepatitis C virus 
sequences covering the 5’ untranslated region (UTR) 
region were sequenced and aligned. 
HCV viral genome is approximately 9.6 kb in 
length. The two regions selected for genotyping 
are the 5’untranslated region (UTR), a highly 
conserved region, and non-structural 5B (NS5B); 
both are often used for genotyping analysis.    
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Figure 4 M13 PCR was utilized to screen colonies indicating 
positive plasmid insertion following TA cloning.  A 216-bp fragment 
covering the 5’UTR region was amplified and cloned, generating 
several hundred TA colonies. Expected fragment size was 372 bp, 
which is indicated above. 
Figure 5 EcoR1 
restriction enzyme 
digestion was employed 
following plasmid DNA 
preparation to verify 
purification and insert (216 
bp). 
1 
56.49 
39.49 
0
10
20
30
40
50
60
1
2
^
∆
∆
𝐶
𝑇
 
Relative quantification 
1st Library
2nd Library
3rd Library
Future Direction 
Our goal is to complete screening and alignment 
of the 5’UTR region and repeat the process at the 
NS5B region to obtain a more comprehensive 
representation of HCV genome variation. Once 
alignment is complete, a phylogenetic tree 
analysis can be conducted. 
 
We aim to utilize next-generation sequencing 
technology to sequence the patient HCV genome 
as a comparison to our phylogenetic analysis. 
